Deerfield Private Design Fund Iii, L.p. - Net Worth and Insider Trading
Deerfield Private Design Fund Iii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deerfield Private Design Fund Iii, L.p. owns 25 companies in total, including Oncorus Inc (ONCR) , CalciMedica Inc (CALC) , and Acutus Medical Inc (AFIB) among others .
Insider Ownership Summary of Deerfield Private Design Fund Iii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCR | Oncorus Inc | 2020-10-01 | director & 10 percent owner & other: *Possible Member of 10% Group |
| CALC | CalciMedica Inc | 2020-09-24 | 10 percent owner & other: Possible Member of 10% Group |
| AFIB | Acutus Medical Inc | 2020-08-05 | director & 10 percent owner & other: Director by Deputization |
 | | 2020-05-28 | director & 10 percent owner & other: Director by Deputization |
| | 2020-03-18 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-03-27 | 10 percent owner & other: *Director by Deputization |
| | 2019-03-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2019-02-08 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-09-26 | 10 percent owner & other: Possible Member of 10% Group |
| | 2018-07-23 | 10 percent owner & other: Possible Member of 10% Group |
| | 2017-10-04 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-10-21 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-07-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-06-29 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-10 | 10 percent owner & other: Possible Member of 10% Group |
| | 2016-02-02 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-10-07 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-09-16 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-07-28 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-05-06 | 10 percent owner & other: Possible Member of 10% Group |
| | 2015-03-25 | 10 percent owner & other: Possible Member of 10% Group |
| | 2014-07-30 | 10 percent owner & other: Possible Member of 10% Group |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
| | 2022-11-08 | director & 10 percent owner & other: * Director by deputization |
Deerfield Private Design Fund Iii, L.p. Trading Performance
Deerfield Private Design Fund Iii, L.p. Ownership Network
Ownership Network List of Deerfield Private Design Fund Iii, L.p.
Ownership Network Relation of Deerfield Private Design Fund Iii, L.p.
Deerfield Private Design Fund Iii, L.p. Owned Company Details
What does Oncorus Inc do?
Who are the key executives at Oncorus Inc?
Deerfield Private Design Fund Iii, L.p. is the director & 10 percent owner & other: *Possible Member of 10% Group of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .
Oncorus Inc (ONCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncorus Inc Insider Transactions
- Download to Excel(.xls)
What does CalciMedica Inc do?
Who are the key executives at CalciMedica Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , director & 10 percent owner & Chief Executive Officer A. Rachel Leheny , and 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp .
CalciMedica Inc (CALC) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 136,737 shares made by Eric W Roberts , a net purchase of 41,768 shares made by A. Rachel Leheny , and a net purchase of 798,842 shares made by Fred A Middleton .
In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 387,154 shares, with a net purchase of 387,154 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,960,290 shares were bought by its insiders, resulting in a net purchase of 1,960,290 shares.
CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CalciMedica Inc Insider Transactions
- Download to Excel(.xls)
What does Acutus Medical Inc do?
Who are the key executives at Acutus Medical Inc?
Deerfield Private Design Fund Iii, L.p. is the director & 10 percent owner & other: Director by Deputization of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .
Acutus Medical Inc (AFIB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acutus Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the director & 10 percent owner & other: Director by Deputization of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc (LRMR) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Larimar Therapeutics Inc (LRMR). Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 57,208 shares made by Thomas Edward Hamilton , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,367,575 shares were bought by its insiders, resulting in a net purchase of 4,367,575 shares.
Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: *Director by Deputization of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
- Download to Excel(.xls)
What does Shockwave Medical Inc do?
Who are the key executives at Shockwave Medical Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Shockwave Medical Inc. Other key executives at Shockwave Medical Inc include Chief Commercial Officer Isaac Zacharias , VP & Finance Trinh Phung , and director & President & CEO Douglas Evan Godshall .
Shockwave Medical Inc (SWAV) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 44,000 shares made by Isaac Zacharias , a net sale of 27,000 shares made by Frank T Watkins , and a net sale of 70,000 shares made by Douglas Evan Godshall .
In summary, during the past 3 months, insiders sold 0 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 213,104 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 213,104 shares.
Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shockwave Medical Inc Insider Transactions
- Download to Excel(.xls)
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Arvinas Inc do?
Who are the key executives at Arvinas Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Arvinas Inc. Other key executives at Arvinas Inc include Chief Accounting Officer David K Loomis , Chief Medical Officer Ronald Peck , and Chief Financial Officer Sean A Cassidy .
Arvinas Inc (ARVN) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 3,023 shares made by Ronald Peck , a net sale of 5,196 shares made by John G Houston , and a net sale of 1,702 shares made by Sean A Cassidy .
In summary, during the past 3 months, insiders sold 460 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 460 shares. During the past 18 months, 12,082 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,082 shares.
Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arvinas Inc Insider Transactions
- Download to Excel(.xls)
What does Aerie Pharmaceuticals Inc do?
Who are the key executives at Aerie Pharmaceuticals Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .
Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerie Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 85,162 shares made by Pamela J. Cramer , and a net sale of 78,894 shares made by Jennifer Chien .
In summary, during the past 3 months, insiders sold 125,174 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 125,174 shares. During the past 18 months, 592,041 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 592,041 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 220,893 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 220,893 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Audentes Therapeutics Inc do?
Who are the key executives at Audentes Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .
Audentes Therapeutics Inc (BOLD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Audentes Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Jason Haas .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does AveXis Inc do?
Who are the key executives at AveXis Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of AveXis Inc. Other key executives at AveXis Inc include director & President & CEO Sean P. Nolan , 10 percent owner Ag Novartis , and Chief Financial Officer Phillip B. Donenberg .
AveXis Inc (AVXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
AveXis Inc Insider Transactions
- Download to Excel(.xls)
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Editas Medicine Inc. Other key executives at Editas Medicine Inc include SVP & CHIEF MEDICAL OFFICER Baisong Mei , director & CEO Gilmore Neil O'neill , and EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 1,988 shares made by Bruce Eaton , a net sale of 32,292 shares made by Baisong Mei , and a net sale of 98,056 shares made by Gilmore Neil O'neill .
In summary, during the past 3 months, insiders sold 2,073 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 2,073 shares. During the past 18 months, 166,559 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 121,559 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
- Download to Excel(.xls)
What does Alimera Sciences Inc do?
Who are the key executives at Alimera Sciences Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .
Alimera Sciences Inc (ALIM) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , and a net purchase of 1,401,901 shares made by Adam Morgan .
In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,401,901 shares.
Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alimera Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
- Download to Excel(.xls)
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , Chief Financial Officer Richard I Eisenstadt , and SVP & General Counsel John M Limongelli .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does SteadyMed Ltd do?
Who are the key executives at SteadyMed Ltd?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of SteadyMed Ltd. Other key executives at SteadyMed Ltd include 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp Vi Llc , and director & 10 percent owner Brian Jay Stark .
SteadyMed Ltd (STDY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.
SteadyMed Ltd Insider Transactions
- Download to Excel(.xls)
What does Adverum Biotechnologies Inc do?
Who are the key executives at Adverum Biotechnologies Inc?
Deerfield Private Design Fund Iii, L.p. is the 10 percent owner & other: Possible Member of 10% Group of Adverum Biotechnologies Inc. Other key executives at Adverum Biotechnologies Inc include Chief Development Officer Setareh Seyedkazemi , Chief Financial Officer Linda M Rubinstein , and Chief Scientific Officer Brigit Riley .
Adverum Biotechnologies Inc (ADVM) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 302,064 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by Linda M Rubinstein .
In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 620 shares of Adverum Biotechnologies Inc (ADVM) were sold and 335,064 shares were bought by its insiders, resulting in a net purchase of 334,444 shares.
Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adverum Biotechnologies Inc Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Deerfield Private Design Fund Iii, L.p. is the director & 10 percent owner & other: * Director by deputization of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Company, L.p. (series C) .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Deerfield Private Design Fund Iii, L.p. is the director & 10 percent owner & other: * Director by deputization of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include Chief Financial Officer Kathleen D. Scott , 10 percent owner & Chief Medical Officer Sarina Tanimoto , and director & 10 percent owner & President and CEO Richard E Lowenthal .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Deerfield Private Design Fund Iii, L.p. made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 1,603,260 shares made by Sarina Tanimoto , a net sale of 1,603,260 shares made by Richard E Lowenthal , and a net sale of 400,000 shares made by Laura Shawver .
In summary, during the past 3 months, insiders sold 2,999,754 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 2,999,754 shares. During the past 18 months, 5,636,274 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 3,301,283 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
Deerfield Private Design Fund Iii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Deerfield Private Design Fund Iii, L.p.. You might contact Deerfield Private Design Fund Iii, L.p. via mailing address: 780 Third Avenue, 37th Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
